Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurological worsening in Wilson disease – clinical classification and outcome
Isabelle Mohr, Jan Pfeiffenberger, Ecem Eker, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 321-328
Closed Access | Times Cited: 14

Showing 14 citing articles:

Deadly excess copper
J. Sailer, Judith Nagel, Banu Akdogan, et al.
Redox Biology (2024) Vol. 75, pp. 103256-103256
Open Access | Times Cited: 21
The mechanism of cuproptosis in Parkinson’s disease
Min Huang, Yong Zhang, Xuehong Liu
Ageing Research Reviews (2024) Vol. 95, pp. 102214-102214
Closed Access | Times Cited: 12
EASL-ERN Clinical Practice Guidelines on Wilson’s disease
Piotr Socha, Wojciech Jańczyk, Alberto Zanetto, et al.
Journal of Hepatology (2025) Vol. 82, Iss. 4, pp. 690-728
Closed Access | Times Cited: 1
Tackling the neurological manifestations in Wilson’s disease – currently available treatment options
Tomasz Litwin, Petr Dušek, Agnieszka Antos, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 12, pp. 1249-1259
Closed Access | Times Cited: 10
A comparative analysis in monitoring 24-hour urinary copper in wilson disease: sampling on or off treatment?
Isabelle Mohr, Patrick Lamade, Christophe Weber, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access
Comparative Analysis of Clinical Outcomes and Safety Profile of Trientine and D-Penicillamine in the Management of Wilson’s Disease: A Systematic Review and Meta-Analysis.
Hafiz Muhammad Arshad, Muhammad Zain Raza, Musab Maqsood, et al.
Rare (2025), pp. 100077-100077
Open Access
Wilson disease combined with polycystic ovary syndrome–clinical features, treatment, and outcome in Chinese patients
Lin Chen, Ming-juan Fang, Liangliang Zhang, et al.
BMC Endocrine Disorders (2025) Vol. 25, Iss. 1
Open Access
Mental and Physical Health in Wilson Disease Patients With SARS‐CoV‐2 Infection and Relevance of Long‐COVID
Isabelle Mohr, Martin Brand, Christophe Weber, et al.
JIMD Reports (2025) Vol. 66, Iss. 3
Open Access
Cuproptosis and copper deficiency in ischemic vascular injury and repair
Jiayi Gu, Wei Huang, Zheng Duanmu, et al.
APOPTOSIS (2024) Vol. 29, Iss. 7-8, pp. 1007-1018
Closed Access | Times Cited: 2
Neurological Deterioration in Wilson's Disease—Types, Etiology, Course, and Management
Tomasz Litwin, Agnieszka Antos, Jan Bembenek, et al.
Discovery Medicine (2024) Vol. 36, Iss. 183, pp. 646-646
Open Access | Times Cited: 1
Aberrant copper metabolism and hepatic inflammation cause neurological manifestations in a mouse model of Wilson’s disease
Jianjian Dong, Guanghai Xiang, Xiaoxue Xia, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Early neurological worsening in Wilson disease: The need for an evidence-based definition
Tomasz Litwin, Anna Członkowska, Łukasz Smoliński
Journal of Hepatology (2023) Vol. 79, Iss. 6, pp. e241-e242
Closed Access | Times Cited: 3
A comparative analysis in monitoring 24-hour urinary copper in Wilson Disease: Sampling on or off treatment?
Isabelle Mohr, Patrick Lamade, Christophe Weber, et al.
Research Square (Research Square) (2024)
Closed Access
Reply to: “Early neurological worsening in Wilson disease: The need for an evidence-based definition”
Isabelle Mohr, Aurélia Poujois, Aftab Ala, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 6, pp. e243-e243
Open Access
Page 1

Scroll to top